Chemoinformaics analysis of 1,2,4-Trithiolane
| Molecular Weight | 124.255 | nRot | 0 |
| Heavy Atom Molecular Weight | 120.223 | nRig | 5 |
| Exact Molecular Weight | 123.948 | nRing | 1 |
| Solubility: LogS | -1.97 | nHRing | 1 |
| Solubility: LogP | 1.48 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 9 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 5 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 4 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 2 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 14.7072 |
| nHD | 0 | BPOL | 8.93283 |
| QED | 0.453 |
| Synth | 5.276 |
| Natural Product Likeliness | -0.003 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.028 |
| Pgp-sub | 0.002 |
| HIA | 0.008 |
| CACO-2 | -5.178 |
| MDCK | 0.00000682 |
| BBB | 0.632 |
| PPB | 0.637914 |
| VDSS | 1.162 |
| FU | 0.20349 |
| CYP1A2-inh | 0.986 |
| CYP1A2-sub | 0.71 |
| CYP2c19-inh | 0.732 |
| CYP2c19-sub | 0.809 |
| CYP2c9-inh | 0.412 |
| CYP2c9-sub | 0.829 |
| CYP2d6-inh | 0.347 |
| CYP2d6-sub | 0.85 |
| CYP3a4-inh | 0.292 |
| CYP3a4-sub | 0.564 |
| CL | 13.016 |
| T12 | 0.782 |
| hERG | 0.029 |
| Ames | 0.818 |
| ROA | 0.946 |
| SkinSen | 0.961 |
| Carcinogencity | 0.063 |
| EI | 0.996 |
| Respiratory | 0.971 |
| NR-Aromatase | 0.022 |
| Antiviral | No |
| Prediction | 0.974667 |